2024-03-29T12:01:57Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_AF08B9212168
2024-03-23T02:50:35Z
serval:BIB_AF08B9212168
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
10.1016/S1470-2045(21)00007-3
000637971400023
33721561
Piccart
M.
author
van 't Veer
L.J.
author
Poncet
C.
author
Lopes Cardozo
JMN
author
Delaloge
S.
author
Pierga
J.Y.
author
Vuylsteke
P.
author
Brain
E.
author
Vrijaldenhoven
S.
author
Neijenhuis
P.A.
author
Causeret
S.
author
Smilde
T.J.
author
Viale
G.
author
Glas
A.M.
author
Delorenzi
M.
author
Sotiriou
C.
author
Rubio
I.T.
author
Kümmel
S.
author
Zoppoli
G.
author
Thompson
A.M.
author
Matos
E.
author
Zaman
K.
author
Hilbers
F.
author
Fumagalli
D.
author
Ravdin
P.
author
Knox
S.
author
Tryfonidis
K.
author
Peric
A.
author
Meulemans
B.
author
Bogaerts
J.
author
Cardoso
F.
author
Rutgers
EJT
author
article
review
2021-04
The Lancet. Oncology
1474-5488
1470-2045
journal
22
4
476-488
Adolescent
Adult
Age Factors
Aged
Anthracyclines/administration & dosage
Breast Neoplasms/drug therapy
Breast Neoplasms/genetics
Breast Neoplasms/pathology
Bridged-Ring Compounds/administration & dosage
Disease-Free Survival
Female
Gene Expression Regulation, Neoplastic/drug effects
Humans
Middle Aged
Neoplasm Metastasis
Taxoids/administration & dosage
Transcriptome/genetics
Treatment Outcome
Young Adult
eng
60_published
peer-reviewed
Publication types: Clinical Trial, Phase III ; Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
Publication Status: ppublish